Trading status Status de
  • Prices realtime
    • Indizes
      • UC DAX
      • UC MDAX
      • UC TECDAX
      • UC DJI
      • UC ESTOXX
      • UC NASQAD 100
    • Shares
    • ETFs & FUNDS
    • Bonds
    • Crypto
  • Screen markets
    • Stock screener
    • Certifcate Screener
    • ETF Screener
    • Fund Screener
    • Bond screener
  • Trading ideas
    • risk indices
      • risk indices
      • EU Intraday
      • EU Long Term
      • US Intraday
      • US Longterm
    • New on gettex
      • New listings stocks
      • New listings bonds
      • New intraday certificates
    • Blog
    • Newsletter
    • Watchlist
    • Support
  • Trading
    • Trading Calendar
    • Extended trading hours
    • Listing on demand
    • Announcements
    • Quality Reports
    • Delayed Data
    • Regulations
    • Become a Trade Participant
    • Cancellations
  • About Gettex
    • FAQs
    • Press
    • Partners
    • Committees
    • Career
    • Career
    • Service & Contact
  • Why gettex

News overview

  • «
  • ‹
  • …
  • 7496
  • 7497
  • 7498
  • …
  • ›
  • »

2025-11-05

Mont Royal Re-Lists on ASX Following Transformational Merger with Commerce Resources

2025-11-05

IDP Education shares drop another 7.5% today: Buy, hold or sell?

2025-11-05

MasterBrand updates 2025 EBITDA guidance to $315M–$335M amid evolving tariff landscape and merger preparations

2025-11-05

Mining services player Austin Engineering downgrades FY26 guidance; shares fall -25%

2025-11-05

Research: Citi Opens 30-day Positive Catalyst Watch on MAOYAN ENT (01896.HK), Keeps Rating at Buy

2025-11-05

Japan Trader Mitsui to Buy Back Up to 200 Billion Yen of Shares

2025-11-05

Clover Health outlines 33% membership growth outlook and targets adjusted EBITDA expansion amid utilization headwinds

2025-11-05

ProAssurance (PRA) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

2025-11-05

Here′s What Key Metrics Tell Us About Rayonier Advanced Materials (RYAM) Q3 Earnings

2025-11-05

Supernus (SUPN) Reports Q3 Earnings: What Key Metrics Have to Say

2025-11-05

Research: CMBI Lifts PICC P&C TP to $23.6, Keeps Rating at Buy

2025-11-05

Personalis narrows 2025 revenue outlook to $68M-$73M amid biopharma project delays and rapid clinical test growth

  • «
  • ‹
  • …
  • 7496
  • 7497
  • 7498
  • …
  • ›
  • »

Preset online depot

Favorites: Zertifikate-Finder FAQs Newsletter
Realtimeprices 17/Apr/2026 12:20:18
Tradingtime Mo-Fr: 7:30-23 h
Certificates 8:00-22 h
  • Imprint
  • Legal notice
  • Data protection
  • Contact
  • Cookies